Spots Global Cancer Trial Database for Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer
Official Title: Phase II Evaluation of Weekly Docetaxel in Combination With Weekly Carboplatin in the Treatment of Recurrent Epithelial Ovarian Carcinoma
Study ID: NCT00214058
Study Description
Brief Summary: The purpose of this study is to determine the safety and efficacy of this regimen in women with ovarian or peritoneal cancer
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States
Contact Details
Name: David M Kushner, MD
Affiliation: University of Wisconsin, Madison
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
